At Memorial Sloan Kettering (MSK), we’re not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we’re driving excellence and improving outcomes.
For the 28th year, MSK has been named a top hospital for cancer by U.S. News & World Report. We are proud to be on Becker’s Healthcare list as one of the 150 Great Places to Work in Healthcare in 2018, as well as one of Glassdoor’s Employees’ Choice Best Place to Work for 2018. We’re treating cancer, one patient at a time. Join us and make a difference every day.
The mission of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology (CMO) is to promote precision oncology through genomic analysis to guide the diagnosis and treatment of cancer patients. The CMO brings together clinicians and scientists throughout MSKCC to establish novel genomic methodologies and conduct large-scale translational research involving molecular characterization of patient tumor specimens in order to identify correlations between genomic features and clinical outcomes.
The Berger laboratory, affiliated with the CMO, is a group of experimental and computational scientists dedicated to the characterization of genetic mutations in human tumors in order to identify biomarkers of cancer progression and drug response. Using massively parallel next-generation DNA and RNA sequencing, the lab is developing and applying methods to profile individual patient-derived specimens including tumor tissue and circulating tumor DNA for somatic base mutations and other genomic aberrations that may influence response to therapy. Having established the capability to prospectively sequence patients’ tumors to enable treatment selection, we are analyzing the vast clinical genomic data set of annotated tumor specimens spanning all cancer subtypes to identify prognostic and predictive biomarkers.
The Berger laboratory is seeking outstanding computational and data scientists with a strong interest in developing and applying bioinformatics methods to problems in translational cancer biology. The candidate will interact with investigators with expertise in computational biology, genomic technologies, molecular pathology, and clinical oncology. The ideal candidate will be an innovative thinker, exceptional communicator, self-motivated, organized, capable of carrying out multiple tasks in a dynamic and fast-paced environment, and will enjoy working with an interdisciplinary team.
MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.
Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require a reasonable accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing documents in an alternate format, using a sign language interpreter, or using specialized equipment.